Literature DB >> 8475090

Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis.

K Kinjoh1, M Kyogoku, R A Good.   

Abstract

We have established a recombinant inbred strain of mouse named spontaneous crescentic glomerulonephritis-forming mouse/Kinjoh or SCG/Kj. Mice of this strain spontaneously develop rapidly progressive glomerulonephritis. This strain of mice was derived from (BXSB/Mp x MRL/Mp-lpr/lpr)F1 hybrid mice by brother x sister mating coupled with repeated histopathologic selection for breeding of mice whose parents had the highest frequency of crescent formation in the kidneys. In this strain of mice, nephritis appears earlier and is more rapidly progressive than in any other murine model of systemic lupus erythematosus. Histopathologically, the characteristic renal lesions in the mice of this strain express a most dramatic form of crescentic glomerulonephritis. The lesions in the kidneys show only slight fine granular immune deposits along the glomerular basement membrane associated with remarkable extraglomerular proliferation and hemorrhage in Bowman's space. Although selection was not based on vasculitis, mice of this strain also exhibit a high incidence of necrotizing vasculitis. These vascular lesions involve primarily small arteries and arterioles and many organs and tissues but spare the kidneys. Thus this form of vasculitis has been found to be correlated with the crescentic form of glomerulonephritis but not with lymphoid hyperplasia of the spleen. We conclude that, in this strain of mouse, the rapidly progressive glomerulonephritis is genetically restricted and that this genetic restriction is firmly linked to that responsible for the vasculitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475090      PMCID: PMC46310          DOI: 10.1073/pnas.90.8.3413

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  ACUTE ANURIC GLOMERULONEPHRITIS.

Authors:  G M BERLYNE; S B DE BAKER
Journal:  Q J Med       Date:  1964-01

2.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

3.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

Review 4.  A clinical and immunopathologic dissection of rapidly progressive glomerulonephritis.

Authors:  R J Glassock
Journal:  Nephron       Date:  1978       Impact factor: 2.847

5.  The morphogenesis of glomerular crescents in rapidly progressive glomerulonephritis.

Authors:  K W Min; F Györkey; P Györkey; J J Yium; G Eknoyan
Journal:  Kidney Int       Date:  1974-01       Impact factor: 10.612

6.  Cellular aspects of rabbit Masugi nephritis. II. Progressive glomerular injuries with crescent formation.

Authors:  Y Kondo; H Shigematsu; Y Kobayashi
Journal:  Lab Invest       Date:  1972-12       Impact factor: 5.662

7.  Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies.

Authors:  P Ronco; P Verroust; F Mignon; O Kourilsky; P Vanhille; A Meyrier; J P Mery; L Morel-Maroger
Journal:  Q J Med       Date:  1983

8.  Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.

Authors:  J Velosa; K Miller; A F Michael
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

9.  Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis.

Authors:  S R Holdsworth; N M Thomson; E F Glasgow; J P Dowling; R C Atkins
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

10.  Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.

Authors:  G J Prud'Homme; C L Park; T M Fieser; R Kofler; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Cellular aspects of vasculitis--T cell-mediated aspects.

Authors:  M E Griffith; C D Pusey
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Antineutrophil cytoplasmic antibody and vasculitis: much more than a disease marker.

Authors:  Vivette D'Agati
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

4.  Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis model.

Authors:  Y Hamano; M Abe; S Matsuoka; D Zhang; Y Kondo; Y Kagami; A Ishigami; N Maruyama; Y Tsuruta; W Yumura; K Suzuki
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

5.  Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.

Authors:  P Heeringa; E Brouwer; P A Klok; M G Huitema; J van den Born; J J Weening; C G Kallenberg
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 6.  Dendritic cells and macrophages in the kidney: a spectrum of good and evil.

Authors:  Natasha M Rogers; David A Ferenbach; Jeffrey S Isenberg; Angus W Thomson; Jeremy Hughes
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

Review 7.  Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Authors:  Ora Shovman; Boris Gilburd; Gisele Zandman-Goddard; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

8.  Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis.

Authors:  V C Primo; S Marusic; C C Franklin; W H Goldmann; C G Achaval; R N Smith; M A Arnaout; B Nikolic
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

9.  Difference in antigenic determinant profiles between human and rat myeloperoxidase.

Authors:  Y C Patry; P H Nachman; M A P Audrain; R J Falk; K Meflah; V L M Esnault
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

10.  Mice with early onset of death (EOD) due to lupus glomerulonephritis.

Authors:  S Honda; K Nemoto; T Mae; K Kinjoh; M Kyogoku; H Kawamura; S Miyazawa; A Weerashinghe; H Watanabe; J Narita; T Koya; M Arakawa; T Abo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.